Table 1 Study population characteristics
| Â | Study Region | Â | Â | Â | Â | Â | Â | ||
|---|---|---|---|---|---|---|---|---|---|
| Â | Karen | Kachin | Chin | Â | Â | Â | Â | Â | |
Number of study sites | 4 | 5 | 4 | Â | Â | Â | Â | Â | Â |
Population | 6176 | 4170 | 4636 | (Total population: 14,982) | |||||
| Â | Â | Â | Â | Â | Percentage of study participants % (number) | ||||
Study participantsb | Karen | Kachin | Chin | Total study participants | Â | RDT result availablea | Pf positive by RDT | Tested by PCR | Pf positive by PCR |
Age <5 years | 459 | 284 | 201 | 17% (944) | 99% (938) | 13% (121) | 34% (327) | 5% (49) | |
5-15 years | 717 | 662 | 522 | 33% (1,901) | 99% (1,881) | 15% (281) | 36% (684) | 7% (138) | |
>15 years | 996 | 947 | 873 | 50% (2,816) | 97% (2,752) | 13% (371) | 34% (964) | 4% (99) | |
Female | 1,152 | 1118 | 801 | 54% (3,071) | 99% (3,038) | 12% (375) | 35% (1,070) | 4% (136) | |
Asymptomatic screening participants | 1,900 | 1,639 | 1,178 | 80% (4,717) | 97% (4,591) | 9% (430) | 32% (1,507) | 3% (157) | |
Febrile clinical patients | 536 | 254 | 427 | 20% (1,217) | 81% (988) | 35% (343) | 42% (506) | 11% (133) | |
Total participants | 2,436 | 1,893 | 1,605 | 5,934 | 94% (5,579) | 14% (773) | 34% (2013) | 5% (290) | |